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Summary
Acceleration of the autoxidation of Fez+ by apotransferrin or apolactoferrin at acid pH is
indicated by the disappearance of Fez+, the uptake of oxygen, and the binding of iron to
transferrin or lactoferrin. The product(s) formed oxidize iodide to an iodinating species and are
bactericidal to Escherichia coli. Toxicity to E. coli by FeS04 (10 -5 M) and human apotransferrin
(100 Ag/ml) or human apolactoferrin (25 Pg/ml) was optimal at acid pH (4.5-5.0) and with
logarithmic phase organisms. Both the iodinating and bactericidal activities were inhibited by
catalase and the hydroxyl radical (OH .) scavenger mannitol, whereas superoxide dismutase was
ineffective. NaCl at 0.1 M inhibited bactericidal activity, but had little or no effect on iodination.
Iodide increased the bactericidal activity of Fez+ and apotransferrin or apolactoferrin. The
formation of OH- was suggested by the formation of the OH- spin-trap adduct (5,5-dimethyl-l-
pyroline N-oxide [DMPO]/OH)., with the spin trap DMPO and the formation of the methyl
radical adduct on the further addition of dimethyl sulfoxide. (DMPO/OH)- formation was inhibited
by catalase, whereas superoxide dismutase had little or no effect. These findings suggest that
Fez+ and apotransferrin or apolactoferrin can generate OH . via an H202 intermediate with
toxicity to microorganisms, and raise the possibility that such a mechanism may contribute to
the microbicidal activity of phagocytes.
T
he role of hydroxyl radicals (OH.)' in the microbicidal
activity of phagocytes is controversial (1, 2). Phagocytes
respond to stimulation with a respiratory burst, and much,
ifnot all, ofthe extra oxygen consumed is converted to highly
reactive oxygen species that contribute to the destruction of
ingested organisms and extracellular targets (2) . The su-
peroxide anion (O~i and H202 are formed by the respiratory
burst, and their interaction in an iron-catalyzed reaction
(Haber-Weiss reaction) to form a powerful oxidant has been
proposed as follows:
H202 + Fez+ - Fe3+ + OH - + OH .
￿
(a)
Oi + Fe3 + - Fez +
￿
+ 02
￿
(b)
01 + H202 - 02 + OH - + OH .
Fe
Although OH. is widely assumed to be the highly reac-
tive species formed (and will be used to designate the ox-
idant here), the formation of other oxidants, such as higher
transition metaloxidation states (3), has been proposed. The
formation of OH. by the Haber-Weiss reaction is limited by
the very low solubility of ferric iron at neutral or alkaline
pH due to the formation ofprecipitates ofpolynuclear hydrated
1 Abbmiations used in this paper. DMPO, 5,5-dimethyl-l-pyrroline N oxide;
EPR, electron paramagnetic resonance; Oi , superoxide anion; OH-,
hydroxyl radical.
iron complexes. Iron can be maintained in solution in a cata-
lytically active form either by lowering the pH (4) or by cer-
tain chelating agents. Thus, iron bound to EDTA retains an
aquo coordination site that can be oxidized and reduced (5,
6), and thus, EDTA considerably increases the formation of
OH. by the iron-catalyzed Haber-Weiss reaction at neutral
pH (7, 8). Other chelating agents, e.g., deferoxamine, are
inhibitory, as they bind to all six coordination sites of iron
displacing water, and these complexes are catalytically inactive.
A biological chelator of iron that, like EDTA, would facili-
tate its oxidation and reduction and thus act as a catalyst of
OH. formation by the Haber-Weiss reaction in vivo has been
sought. Iron-saturated lactoferrin has been reported to cata-
lyze the Haber-Weiss reaction (9, 10); however, others have
been unable to detect catalysis of OH. formation by iron-
saturated lactoferrin in the absence of extraneous iron (11-13),
and apolactoferrin or partially-saturated lactoferrin has been
reported to inhibit the iron-catalyzed Haber-Weiss reaction,
presumablyby the chelation of free iron in an unreactive form
(13, 14). Similarly, transferrin has been reported to catalyze
the Haber-Weiss reaction in some studies (15, 16), but not
others (13, 17), and the inhibition of OH. formation by un-
saturated transferrin has been reported (13, 14). Other bio-
logically relevant iron chelators reported to facilitate iron-
dependent OH . formation, include ferritin (18), phosphate
(19), ot-picolinic acid (20), phosphonucleotides (21-23), and
DNA (24), although several of the iron chelates are more
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catalysts of the Haber-Weiss reaction (25).
An additional mechanism by which iron-chelating agents
can increase iron-dependent oxygen-centered free radical for-
mation is by facilitating the autoxidation of iron. Chelating
agents stimulate the autoxidation of Fel+ best when the
affinity of the chelator for Fel+ greatly exceeds its affinity
for Fez+ (26). At pH 7.0, Fe3+-chelating agents enhance the
autoxidation of Fez+ in the order EDTA ti dinitrilodiace-
tate > citrate > phosphate > oxalate (27). Deferoxamine binds
Fe3+ with very high avidity, whereas it binds Fez+ poorly,
if at all, and thus would be expected to promote Fel+ au-
toxidation. We have recently reported that the autoxidation
of Fez' at pH 5.5 is greatly accelerated by deferoxamine
with the formation of products (H202, OH-) that are toxic
to bacteria (28), which is in sharp contrast to the inhibitory
effect ofdeferoxamine on OH. formation by the iron-catalyzed
Haber-Weiss reaction. The prooxidant activity of deferoxa-
mine also has been described by others, (29-31). In this paper,
we report that apotransferrin and apolactoferrin also can ac-
celerate the autoxidation of Fez+ at acid pH with the for-
mation ofan oxidant or oxidants with cytotoxic properties.
Materials and Methods
SpecialReagents.
￿
Humanapotransferrin, human holotransferrin,
and bovine apotransferrin were obtained from Boehringer Mann-
heim Biochemicals, Indianapolis, IN . Human milk lactoferrin was
obtained from Calbiochem-Behring Corp., San Diego, CA, and
its iron was removed to form apolactoferrin as described (32). Briefly,
10 mg of lactoferrin were dissolved in 2 ml of 0.2 M sodium ace-
tate buffer containing 40 mM EDTA and 0.2 M sodium phosphate,
pH 4.0. The solution was kept overnight at 4°C and dialyzed for
3 d against 4 liters of water with three water changes, and lyophi-
lized.Iron-saturated hololactoferrinwas prepared from apolactoferrin
as described (33). Catalase (CTR; bovine liver, 84,150 U/mg) was
obtained from Worthington Biochemical Corp., Freehold, NJ; su-
peroxide dismutase (bovine erythrocyte, 3,150 U/mg), human al-
bumin (essentially fatty acid free prepared from fraction V), and
DMSO from Sigma Chemical Co., St. Louis, MO; 5,5-dimethyl-
1-pyrroline N-oxide (DMPO) from Aldrich Chemical Co., Mil-
waukee, WI; and Nal"I (NEZ033) and "FeS04 (NEZ049) from
DuPont-NewEngland Nuclear, Boston, MA. The catalase was di-
alyzed overnight against water before use. The catalase was heated
at 100°C for 20 min, and the superoxide dismutase was heated
at 121°C for 30 min in an autoclave where indicated.
BactericidalActivity.
￿
Escherichia coli (ATCC 11775; American Type
Culture Collection, Rockville,MD) was maintained on blood agar
plates and, just before the experiment, transferred to Trypticase
soy broth (BBL Microbiology Systems, Cockeysville, MD) and
grown on a Roto-Rack (Fisher Scientific Co., Pittsburgh, PA)
rotating 15 times per minute for 2 h unless otherwise indicated.
The organisms were collected by centrifugation, washed twice with
0.1 M Na2S04 and suspended in 0.1 M Na2SO4 to the required
absorbency at 540 nm. The E. coli were incubated with the compo-
nents indicated in the legends to the figures and tables in a final
volume of 0.5 ml for 60 min at 37°C unless otherwise indicated,
and the viable cell count was determinedby the pour-platemethod
using Trypticase soy agar (34).
Iodination.
￿
The reagents indicated in the legends to the tables
were incubated in polystyrene test tubes (12 x 75 mm) for 60 min
1294
￿
Toxicity Induced by Fez+ and Transferrin or Lactoferrin
at 37°C without shaking, and iodination was determined as previ-
ously described (28). Each experimental value was determined in
duplicate and was averaged to give a single value for statistical
analysis.
Fez' Measurement.
￿
The components of the reaction mixture
(see legends to figures) in a final volumeof0.5 ml were incubated
at 37°C in a shaking water bath for the periods indicated. 50 JAI
of 0.01 M bathophenanthroline sulfonate was added, and the OD
at 535 nm was compared with a ferrous sulfate standard curve (35).
Oxygen Consumption.
￿
Oxygen consumption was determined
with a Clark-type oxygen electrode (Yellow Springs Instrument
Co., Yellow Springs, OH) at 37°C and expressed as nmol/ml based
on a concentration of 215 )AM Oz in air-saturated buffer at 37°C.
Binding of s9Fez+ to Tmnsferrin.
￿
The components of the reac-
tion mixture (see legends to figures) containing 59Fe" were in-
cubated for 15 min, and the total reaction mixture (0.5 ml) was
separated at room temperature on a prepacked disposable 16 x 50-
mm Sephadex G25 column (9.1-mlbed volume) (PD-10, Sephadex
G25M; Pharmacia Fine Chemicals, Uppsala, Sweden) that had been
prewashed with 30 ml of 5 x 10 - ° M sodium acetate buffer, pH
5.0. The fractions (0.5 ml) were eluted with the same buffer at
a flow rate of tit ml/min and counted with a gammascintillation
counter. A standard containing the total amount of 59Fe added to
the reaction mixture was counted for calculation of percent recovery.
The protein content of the fractions was estimated by the absorp-
tion at 280 urn.
Electron Paramagnetic Resonance (EPR) Spectroscopy.
￿
The com-
ponents ofthe reaction mixture (see legends to figures) were mixed
and immediately transferred to a flat cell placed in the cavity of
an EPR spectrometer (E3; Varian Associates, Inc., Palo Alto, CA),
and the EPR spectrum was determined at room temperature. Mea-
surements were with a scan speed of 12.5 Gauss/min, modulation
amplitude of 5 G, timeconstant of 3 s, X band frequency of 9.43
GHz, field centered at 3,345 G, receiver gain at 106, and power
at 20 mW. Where indicated, scans from the XY recorder of the
EPR instrument were digitized at 0.1-Gauss intervals using a
digitizing tablet and accompanying software (Sigma-Plot; Jandel
Scientific, San Francisco, CA). Digitized scans were transferred to
a spreadsheet program (Lotus 123; Lotus Development Corpora-
tion, Cambridge, MA), where redundant values were averaged,
missing values linearly interpolated, multiple scans summed, and
subtraction of scans performed.
Statistical Analysis.
￿
The data are expressed as the mean ± SE.
Statistical differences are determined using student's two-tailed t
test for independent means (NS, p > 0.05). In the analysis of the
bactericidal data, logarithmically transformed data are utilized for
the determination of p values (34).
Results
Bactericidal Activity.
￿
Under the conditions used in Fig. 1,
Fel+ alone at relatively high concentration was toxic to E.
coli in acetate buffer pH 5.0. When the concentration of
Fez + was lowered to a level where little or no toxicity was
observed, the further addition of human apotransferrin or
apolactoferrin significantly increased toxicity. In Fig. 2, the
Fez+ concentration was maintained at 10 -5 M, and the
humanapotransferrin and apolactoferrin concentrations were
varied. The bactericidal activity increased with the apotrans-
ferrin or apolactoferrin concentrations to a maximum at 100
Ag/ml (N1.3 x 10 -6 M) and 25 p.g/ml (N0.3 x 10 -6 M),
respectively, and then fell as the concentration was further1077
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Figure 1.
￿
Bactericidal effect of
Fe2+ and apotransferrin or apo-
lactoferrin. Thereaction mixture
contained 5 x 10-4 M sodium
acetate buffer pH 5.0, 0.01 M
NaaSO4, 1-3 x 106E. coli, FeS04
at theconcentrations indicated, ei-
ther alone(A), orwith 100kg/ml
ofhumanapotransferrin(0)or 25
hg/mlhumanapolactoferrin (O).
Theresults arethe mean of three
to seven experiments. The aster-
isks indicate asignificantdifference
1021...
￿
between Fez+ aloneand Fez+ +
0
￿
105 ￿10 4
￿
0
￿
transferrin or Fez+ + lactoferrin
Ferrous Sulfate (M)
￿
(all p < 0.001).
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104
increased. A bactericidal effect also was observed with Fe2+
and bovine apotransferrin with theoptimum transferrin con-
centration being25 jug/ml (data not shown). All subsequent
bactericidal studies were performed with FeS04, human
apotransferrin, and human apolactoferrin concentrations of
10-5 M, 100 hg/ml, and 25 jig/ml, respectively.
Table 1 demonstrates the effect of pH on the bactericidal
effect of Fez+, Fe2+ + apotransferrin, or Fe2+ + apolac-
toferrin. Fe2+ alone at 10-5 M, while ineffective at pH 4.5
and 5.0, wasbactericidal when thepH was increasedto 5.5-7.0
with either acetateor phosphatebuffer. Thefurther addition
of apotransferrin significantly increased bactericidal activity
in acetate buffer pH 4.5 and5.0, and apolactoferrin increased
bactericidal activity in acetate buffer pH 4.5-5.5. At the higher
pH levels, there was a tendency for the chelators to inhibit
0
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Figure 2.
￿
Effect of transferrin or lactoferrin concentration. The reac-
tion mixture contained 5 x 10-4 M sodium acetate buffer, pH 5.0,0.01
MNa2SO4, 1-2 x 106 E. coli, 10-5 M FeS04, andeither apotransferrin
(0) or apolactoferrin (O) at theconcentrations indicated. Theresults are
themean of three to five experiments. Theasterisks indicate a significant
difference from control without transferrin or lactoferrin (p < 0.05).
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Thereaction mixturecontained 5 x 10 -4 M sodium acetate or sodium
phosphate buffers at the pH indicated, 0.01 M Na2SO4, 1-3 x 106 E
coli, and, where indicated, 10 -5 M FeSO4, 100 ug/ml apotransferrin
(apoTR), and 25 Rg/ml apolactoferrin (apoLF). Results are the mean
of three to seven experiments.
` Significantly different from control, p < 0.05.
t Significantly different from Fe2+ alone, p < 0.05.
the toxicity of iron. All, subsequent studies were performed
with acetate buffer pH 5.0.
TheE. coli routinelyused were in logarithmic growth phase,
having been grown in brothfor 2 h before isolation and use.
As shown in Fig. 3, the bactericidal effect of Fe2+ and
apotransferrin or apolactoferrin was high with organisms
grownin broth for 1 or 2 h, and then declined as thegrowth
period was extended to 24 h.
The time course of the toxicity of Fe2+ + apotransferrin
and Fe2+ + apolactoferrin under our standard conditions is
shownin Fig. 4. A significant bactericidal effect was observed
at 5 min with both systems, with toxicity increasing with
the incubation period as shown.
Figure 3. Effect of E. coli
growth period. Thereaction mix-
ture contained 5 x 10 -4 M so-
dium acetate buffer, pH 5.0, 0.01
M Na2SO4, 2-5 x 106 E. coli
growninbrothfor theperiodsin-
dicated, and further additions as
follows: none (0); 10-5 M
FeS04 + 100 ug/ml apotrans-
ferrin (0); 10-5 MFeS04 + 25
Icg/ml apolactoferrin (O). The
results are the mean of three to
seven experiments. The asterisks
indicate a significant difference
from the control without addi-
tions (p < 0.05).
Table 1. Effect ofpH
Viable cell count
Buffer pH Control Fe2+ Fee+ +apoTF Fez+ +apoLF
organisms/ml x 10-6
Acetate 4.5 2.30 1.92 0.15"t 0.20't
Acetate 5.0 3.17 2.35 0.065*$ 0.43'4
Acetate 5.5 2.78 1.44" 0.75" 0.45"t
Acetate 6.0 2.86 0.28" 0.10` 1.36"
Phosphate 6.0 3.07 0.55" 1.25' 1.64"
Phosphate 6.5 2.21 0.022' 0.26" 0.86"
Phosphate 7.0 2.30 0.011" 0.35" 0.36"U
n
io
104
Table 2.
￿
Effect of inhibitors
Figure 4.
￿
Effect of incubation
period. Thereaction mixturecon-
tained 5 x 10 -4 M sodium ace-
tate buffer, pH 5.0, 0.01 M
Na2SO4, 1-3 x 106 E. coli, ei-
ther alone(control) (A), or with
10-5 M FeS04 + 100 149/ml
apotransferrin (0) or 10- 5 M
FeS04 + 25 ug/ml apolac-
toferrin (O). The incubation
period was varied as indicated.
Results arethemean of three to
seven experiments. The asterisks
indicate a significant difference
Time (min)
￿
from control (all p < 0.001).
10 - 30
￿
50 - 70 - 90
In the Fe2+ + apotransferrin or apolactoferrin system,
Fee+ could not be replaced by Fe3+, and bactericidal activity
was inhibited by catalase at 5.8 /Ag/ml, but not by heated
catalase or by superoxide dismutaseat 5F,g/ml (Table 2). Man-
nitol also was inhibitory at 0.1 M, as was NaCl. Comparable
inhibition was observed in both systems when NaCl was
replaced by equimolar concentrations of KCI, NaBr, or
Na2S04 (data not shown). Apotransferrin or apolactoferrin
at the concentration used in Table 2 was ineffective in the
absence of Fee+, as was an equal concentration of holotrans-
ferr;n or hololactoferrin (Table 2). Holotransferrin at higher
concentration (1,000 Nzg/ml), however, was toxic to E. coli;
this toxicity was unaffected by catalase at 5.8 or 58 1~g/ml
Table 3.
￿
Stimulation of the Bactericidal Effect of Fez+ and
Apotransferrin or Apolactoferrin by Iodide
The reaction mixture contained 5 x 10-4 M sodium acetate buffer, pH
5.0, 0.01 M Na2SO4, 3 x 106 E. coli, and, where indicated, 10-5 M
FeS04, 100 t~g/ml apotransferrin (apoTF), 25 jig/ml apolactoferrin
(apoLF), and 10 -5 M Nal. The results are the mean of three to four
experiments.
p value for the difference from Fez+ + apoTF or Fez* + apoLF.
and by superoxide dismutase at 5 /~g/ml, but was inhibited
by mannitol and NaCl at 0.1 M (data not shown) .
Earlier studies had indicated that thebactericidal activity
of Fe2+ + H202 (Fenton's reagent) was considerably in-
creased by the addition of iodide (36). Table 3 demonstrates
the stimulatory effect of iodide at 10-5 M on the bacteri-
cidal effect of Fe2+ and apotransferrin, or Fee+ and apolac-
toferrin.
Thereacton mixture contained5 x 10-4 M sodium acetate buffer, pH 5.0, 0.01 M Na2SO4, 3 x 106 E. coli, and, whereindicated, 10-5 MFeS04,
10-5 M Fe2(SO4)3, 100 wg/ml apotransferrin (apoTF), 100 wg/ml holotransferrin (holoTF), 25 !+g/ml apolactoferrin (apoLF), 25 Ug/ml hololac-
toferrin (holoLF), 5.8 Wg/ml catalase, 5 t~g/ml superoxide dismutase (SOD), 0.1 M mannitol, and 0.1 M NaCl.
' p value for the difference from control (none).
tp value for the difference from Fe2+ + apoTF or apoLF.
5 Mean of no. of experiments.
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Additions Transferrin p
*
Viable cell
pt
count
Lactoferrin p
* pt
organisms/ml x 10-6
None 3.05(6)S 3.40(4)
Fe2+ + apoTF or apoLF 0.05(6) <0.002 0.19(4) <0.001
- Fez+, + Fe3+ 3.83(3) NS <0.02 2.27(4) <0.001 <0.001
+ catalase 2.50(6) NS <0.002 2.64(4) <0.02 <0.001
+ heated catalase 0.03(6) <0.01 NS 0.62(4) <0.001 <0.05
+ SOD 0.08(6) <0.01 NS 0.27(4) <0.001 NS
+ mannitol 0.92(4) <0.05 <0.05 2.41(4) <0.02 <0.001
+ NaCl 2.09(5) NS <0.01 2.61(4) NS <0.001
ApoTF or apoLF 2.12(10) NS <0.001 2.74(6) NS <0.001
HoloTF or holoLF 1.94(9) NS <0.001 2.47(3) NS <0.01
Additions Viable cell count p"
organisms/ml x 10-6
None 2.83
Fez* + apoTF 0.35
Fez+ + apoTF + 1 0.00005 <0.002
Fez' + apoLF 0.11
Fe2' + apoLF + 1 0.00003 <0.001Iodination.
￿
Incubation of Fee+ and apotransferrin or apo-
lactoferrin with 1251-iodide in the presence of albumin was
associated with the conversion ofiodide to a TCA precipitable
form (iodination) . When the Fee+ concentration was main-
tained at 10-5 M, iodination increased with the apotrans-
ferrin or apolactoferrin concentrations to a maximum at 100
h.g/ml (ti1.3 x 10-6 M) and 50 Ag/ml (ti0.6 x 10-6 M),
respectively, and then fell .sharply as the chelator concentra-
tion was further increased (data not shown) . Under the con-
ditions used in Table 4, iodination by Fee+ and apotrans-
ferrin or apolactoferrin was significantly decreased or abolished
when either Fee+ or the iron chelator was omitted, when
Fee + was replaced by Fe3+, or when catalase was added. The
inhibition by catalase was prevented by its heat-inactivation.
Superoxide dismutase at 5 F.g/ml did not significantly de-
crease iodination. Mannitol was inhibitory at 0.1 M; how-
ever, in contrast to its inhibition ofbactericidal activity, NaCl
at 0.1 M did not inhibit iodination by Fez+ and apotrans-
ferrin, and only partially inhibited iodination by Fee+ and
apolactoferrin. No iodination was observed when Fee+ +
apotransferrin was replaced by holotransferrin at 100-1,000
Ag/ml, or when Fee+ + apolactoferrin was replaced by
hololactoferrin at 10-500 Ag/ml.
Autoxidation ofIron.
￿
The autoxidation of Fee + is greatly
accelerated by apotransferrin or apolactoferrin at pH 5.0. Under
the conditions used in Fig. 5, a rapid loss of Fee+ (half max-
imal, -10 s) was observed on incubation with apotransferrin
or apolactoferrin at the concentrations routinely used for the
measurement of bactericidal activity. Total disappearance of
Fe2+ was not observed under these conditions, with -32%
of the Fe2+ remaining after a 15-min incubation with 100
Ftg/ml of apotransferrin, and -54% remaining after a 15-
The reaction mixture contained 5 x 10-4 M sodium acetate buffer, pH 5 .0, 8 x 10-6 M Nal (4,000 pmol; 0.05 tiCit251), 0.2 mg/ml albumin,
and, where indicated, 10-5 M FeS04, 100 tug/ml apotransferrin, 50 ug/ml apolactoferrin, 10-5 M Fe3(SO4)2, 5.8 ug/ml catalase, 5 Eg/ml superoxide
dismutase (SOD), 0.1 M mannitol, and 0.1 M NaCl in a final volume of 0.5 ml.
' p value for the difference from Fe2' + apoTF or Fe2+ + apoLF.
t Mean ± SE of no. of experiments.
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min incubation with 25 leg/ml of apolactoferrin. However,
when the apotransferrin and apolactoferrin concentrations were
increased to 250 and 100 Ag/ml, respectively, essentially com-
plete disappearance of Fee+ was observed at 15 min. Loss of
Fe2+ was not observed in the absence of apotransferrin or
apolactoferrin under the conditions used in Fig. 5.
That the loss of Feel is due to its autoxidation is sug-
gested by measurements of oxygen consumption. Little,or
no oxygen consumption was detected at the concentrations
of Fee+ (10 -5 M) and apotransferrin (100 kg/ml) routinely
used in bactericidal studies. Since the concentration of ox-
ygen in air-saturated buffer at 37°C is 215 AM, and the con-
centration of the Fee+ used under our standard conditions
is 10 AM, uptake of only a small percentage of the oxygen
would be expected, thus making detection difficult. When
the concentration of Fee+ and apotransferrin were increased
2-, 5-, 10-, and 20-fold with the ratio kept constant, a rapid
uptake of oxygen was observed that was essentially complete
in 30 s. At the highest concentrations used (Fe2+, 2 x 10-4
M; apotransferrin, 2 mg/ml), no oxygen consumption was
observed on the addition of either Feel or apotransferrin
alone. Assuming the oxidation of two-thirds of the Fez+
added (Fig. 5), approximately one molecule of oxygen is taken
up for every three or four molecules of Fee+ oxidized.
Similar findings were observed with apolactoferrin, except
that the oxygen/Fe2 + stoichiometry was 1:2-3.
Binding of Iron.
￿
The binding of iron on incubation of
Fe2+ with apotransferrin at pH 5.0 was indicated by the as-
sociation of 59Fe2+ with the iron-binding protein (Fig. 6).
In the absence of transferrin, 59Fe2+ eluted from a Sephadex
G25 column in small amounts over an extended period. How-
ever, after a 15-min incubation of 10-5 M 59FeSO4 with 100
Table 4. Iodination by Fe' and Apotransferrin or Apolactoferrin
Additions Fe2+ + apoTF
Iodination
Fe2+
pmol
+ apoLF p*
Fe2' 1.1 ± 1.1(3)# <0.01 0.8 ± 0.7(4) <0.001
ApoTF or apoLF 3.7 ± 0.1(3) <0.01 -1 .8 ± 0.2(2) <0.001
Fe2+ + apoTF or ApoLF 45 .7 ± 7.2(3) 85.2 ± 4.9(6)
Fe3' + apoTF or apoLF 4.1 ± 0.5(3) <0.01 1.4 ± 2.0(5) <0.001
Fe2' + apoTF or apoLF + catalase 2.9 ± 0.5(3) <0.01 0.3 ± 0.4(3) <0.001
Fe' + apoTF or apoLF + heated catalase 32.4 ± 5.2(3) NS 78.8 ± 9.6(3) NS
Fe21 + apoTF or apoLF + SOD 33 .9 ± 6.3(3) NS 70.1 ± 3.6(4) NS
Fe2+ + apoTF or apoLF + mannitol 2.0 ± 0.1(3) <0.01 0.9 ± 0.8(5) <0.001
Fe2+ + apoTF or apoLF + NaCl 47 .3 ± 7.1(5) NS 27.3 ± 3.0(5) <0.001Time (min)
Figure 5. Fe2+ disappearance on incubation with apotransferrin or
apolactoferrin. The reaction mixture contained 5 x 10-4 M sodium ace-
tate buffer, pH 5.0, 10-5 M FeS04 alone (x . . . x) or 10- 5 M FeS04,
and either apotransferrin (broken lines) ([0---01 50 Fog/ml; [A---0]
100 Fog/ml; [0---p] 250 Rg/ml) or apolactoferrin (solid lines) ([M-0]
25,ug/ml; [0-0] 50 ttg/ml; [A-A] 100 Rg/ml) in a final volume
of0.5 ml. After incubation for the times indicated, bathophenanthroline
sulfonate was added for determination of Fe2+ remaining in the reaction
mixture. The results are the mean ± SE of three experiments.
P.g/ml apotransferrin at pH 5.0, 40.4 ± 0.7% (SE, n = 3)
of the added iron eluted as a peak in fractions that corresponded
to the transferrin protein peak, as indicated by 280-nm ab-
sorption. When apotransferrin was replaced by an equiva-
lent concentration of holotransferrin, 1.9 ± 1.9% (SE, n =
2) of the radioactivity was detected in the transferrin peak.
Similarly, when "Fe2+ was incubated with 25 p,g/ml apolac-
toferrin, 86.5 ± 0.5% (SE, n = 2) of the iron eluted with
the protein peak, as compared with 17.5 ± 1.6% (SE, n =
3) when hololactoferrin was used.
Formation o .f the (DMPO1OH). Adduct.
￿
The incubation
of 10-5 M FeS04 and 100 hg/ml human apotransferrin with
the spin-trap DMPO in acetate buffer pH 5.0 produced an
EPR signal with splitting constants of aN=aH=14.8 G and
a 1:2:2:1 intensity distribution (Fig. 7 C), which was not
observed when either Fe2+ or transferrin was added alone
(Fig. 7, A and B). The signal was the same as that reported
for the (DMPO/OH). adduct (37-39) and that produced by
FeS04 and H202 (Fenton's reagent), which generates OH.
(datanot shown). The production ofthe (DMPO/OH). signal
by Fe2+ and transferrin was abolished by catalase (Fig. 7 D),
but not by heated catalase (Fig. 7 E). The (DMPO/OH) .
signal was consistently decreased but not abolished by su-
peroxide dismutase at 25 wg/ml (Fig. 7 F), an effect that was
partially reversed when heated superoxidedismutase was used
(Fig. 7 G). When the superoxide dismutase concentration
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Figure 6.
￿
Binding of S9Fe2+ to apotransferrin. The reaction mixture
contained 5 x 10-4 M sodium acetate buffer, pH 5.0, 10 -5 M FeS04
(-14,000 cpm) (dotted line) or 10-5 M 59FeS04 + 100 tcg/ml human
apotransferrin (apoTF) (solidline)in a final volume of0.5 ml. After separa-
tion on a Sephadex G25 column, the 59Fe present in the fractions (FeS04
alone, dotted line; FeS04 + apoTF, solid line) and the absorbency at 280
nm (FeS04 + apoTF, broken line) was determined. The results are the
mean of three experiments.
was lowered to 5 Ag/ml, its inhibitory effect was lost, and
when its concentration was raised to 50 Ag/ml, a comparable
inhibition was observed with the heated preparation, sug-
gesting anonspecific effect (data not shown). Methyl radicals
(CHI ), formed by the reaction of OH- with DMSO, react
with DMPO to form the (DMPO/CH3). adduct, which has
a characteristic EPR signal (1). When DMSO was added to
the Fee+ + transferrin system, a complex EPR signal was
observed (Fig. 7 H). Subtraction of the (DMPO/OH). signal
yielded a signal with splitting constants of AN =16.2 G and
AH =23.1 G (Fig. 7 I), which is characteristic of the
(DMPO/CH3). adduct (40). No EPR signal was observed
on the addition of holotransferrin at 100 P,g/ml in the pres-
ence or absence of Fez' (data not shown) or holotransferrin
at 1,000 Ag/ml (Fig. 7j) under our experimental conditions.
Similarly, under conditions identical to those used in Fig.
7, an EPR signal characteristic of the (DMPO/OH). adduct
was observed on the incubation of 10-5 M Fez+ with 25
Fog/ml apolactoferrin, which was not seen with either Fe2+
or apolactoferrin alone, or when apolactoferrin was replaced
by holotransferrin in the presence or absence of Fe2+ (data
not shown) . (DMPO/OH). adduct formation by Fe2+ and
apolactoferrin was largely inhibited by catalase (1.2 Ag/ml),
but not by heated catalase. A small inhibition by superoxide
dismutase (25 Wg/ml) was observed that also was present when
the heated preparation was used.
Discussion
We report here that incubation of Fez' with apotrans-
ferrin or apolactoferrin results in the autoxidation of Fe2+with the formation of oxidants that convert iodide to an io-
dinating species and are toxic to E. coli. Evidence for the for-
mation of two oxygen reduction products, H202 and OH.,
was obtained. Rather precise conditions were required: an
acid pH (4.5-5.5); Fee+ at a concentration (10-5 M) just
below that at which it was toxic alone; apotransferrin or
apolactoferrin over a narrow concentration range abovewhich
activity was lost; and organisms in early logarithmic growth
phase. Our findings will be discussed in relation to the fol-
lowing sequence of reactions:
2Fe2 + + apoTF (or apoLF) + 202 --" 2Fe3+ + 201
￿
(d)
TF (or LF)
2 01 + 2H+- 02 + H202
￿
(e)
H202 + Fe2 + - Fe3 +OH- + OH. (a)
where TF is transferrin, LF is lactoferrin, apoTF is apotrans-
ferrin, and apoLF is apolactoferrin. This sequence of reac-
tions would predict an 02/Fe2+ stoichiometry of 1:3, which
is approximately what was found.
The autoxidation ofFe2 + has a second order dependence
on the OH- concentration (41) and thus is favored by an
increase in pH. At the pH used here (5.0), autoxidation is
very slow, but is greatly accelerated by apotransferrin or apolac-
toferrin, as indicated by the disappearance of Fe2 +, the up-
take of oxygen, and the binding of iron to the protein. It
has been suggested that Fe2 + can bind to apotransferrin at
the specific binding site, and that the Fe2+ at this site is
highly susceptible to oxidation (42). Other investigators, how-
ever, have been unable to detect appreciable binding ofFe2+
to transferrin (43, 44), and it is the generally held view that
iron bindsto transferrin and lactoferrin largely ifnot entirely
in the Fe3 + form, with each molecule of transferrin or lac-
toferrin capable of binding two atoms of Fe3+ to specific
iron-binding sites. Thus, transferrin or lactoferrin, incommon
with otherchelators such as deferoxamine (28), which have
a much greater affinity for Fe3 + than for Fe2 +, may ac-
celerate the autoxidation of Fe2+ in part by the chelation of
the Fe3+ formed. However, this does not appear to be the
sole mechanism since, under our optimum conditions, Fe2+
disappearance exceeded the iron-binding capacity of trans-
ferrin and lactoferrin. Iron is released from holotransferrin
as the,pH is lowered below neutrality (45), with one of the
two iron-binding sites dissociating at a higher pH than the
other (46, 47). Lactoferrin binds iron more avidly than does
transferrin (48) but, like transferrin, has one iron-binding site
that is more acid labile than the other (33). At pH 5.0, some
dissociation ofthe iron-binding sites would be expected, and
possibly transient binding occurs with release of iron into
the medium. Some nonspecific binding of iron to the pro-
tein cannot be excluded.
Although the formation of 0-1 would be anticipated as a
consequence of the one electron reduction of oxygen by
Fe2+ (reaction d), we were unable to appreciably modify the
toxicity by the addition of superoxide dismutase, although
there was some suggestion of a heat-reversible inhibition of
(DMPO/OH) . formation. Possible explanations compatible
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Figure 7.
￿
Radical formation measured by EPR. The reaction mixture
contained 5 x 10 -4 M sodium acetate buffer, pH 5.0, 0.1 M DMPO, -
and, where indicated, 10- 5 M FeS04, 100,ug/ml human apotransferrin
(apoTF), 1,000 Wg/ml human holotransferrin (holdTF), 1.2 Ftg/ml cata-
lase, 25 Ag/ml superoxide dismutase (SOD), and 0.7 M DMSO in a final
volume of 0.5 ml. The catalase and SOD were heated where indicated.
The tracings are the sum of three or four replicates, with the tracing for
DMPO in buffer alone subtracted from each. Tracing I is a difference spec-
trum of tracing H minus tracing C. The arrows in tracing I indicate
the points where peak lines crossed zero, from which splitting constants
AN= 16.2 G and AH=23.1 G were calculated.
with an O intermediate are the formation ofan O complex
inaccessible to superoxide dismutase, or the rapid spontaneous
dismutation of 01 at the pH used, making catalysis unnec-
essary. The formation of H202 by the Fe2 +-transferrin or
Fe2 +-lactoferrin system and its involvement, either directly
or indirectly, in the toxicity is indicated by catalase inhibi-
tion of (DMPO/OH). formation, iodination, and bacteri-
cidal activity. In each instance, the inhibition by catalase was
partially or totally prevented by its heat inactivation. H202
may be formed by the dismutation of Oi (reaction e) or by
the divalent reduction by oxygen without an Oi inter-
mediate.
The formation of OH . was suggested by the detection by
EPR of the (DMPH/OH)- adduct on the addition of the
spin-trap DMPO to the Fe2 +-transferrin or Fe2+-lactoferrinsystem. The (DMPO/OH). adduct can be formed either by
the reaction of OH . with DMPO oryby the reduction of the
(DMPO/OOH). adduct formed by reaction of O with
DMPO as follows:
OH. + DMPO - (DMPO/OH) .
T
01 + DMPO - (DMPO/OOH).
The strong inhibition of (DMPO/OH)- adduct formation
by catalase and the little or no inhibition by superoxide dis-
mutase would argue against an intermediate requirement for
(DMPO/OOH) . . DMSOreacts with OH- to form the methyl
radical (CHI ), which can be detected as the (DMPO/CH3)-
adduct. The detection of the (DMPO/CH3)- adduct on the
addition of DMSO to the Fee+-transferrin system is further
evidence for the formation of OH . .
The H202, generated by the autoxidation of Fez+, would
be expected to react with excess Fez+ (Fenton's reagent) to
generate OH. (reaction a). It is of interest in this regard that
the Fe2+ was not totally utilized at the optimal transferrin
or lactoferrin concentration used, indicating that Fez+ would
be available for interaction with the H202 formed. When
the transferrin or lactoferrin concentration was increased to
a level where the Fe2+ totally disappeared, toxicity was lost.
The potentiation of bactericidal activity by iodide (36) and
the inhibition ofbactericidal activity by the OH- scavenger
mannitol at 0.1 M is compatible with OH. involvement in
the toxicity. High salt concentration (0.1 M NaCl, NaBr,
KCI, Na2S0a) also inhibited bactericidal activity, raising the
possibility of a nonspecific solute effect. However, 0.1 M man-
nitol also abolished iodination, whereas equimolar NaCl was
ineffective (transferrin) or only partially inhibitory (lactoferrin),
raising the possibility that hypotonicity is an additional re-
quirement for bactericidal activity.
The importance of the composition of the bacterial cell
wall in the toxicity is indicated by the requirement for early
growth phaseE. coli. The chemical composition ofbacterial
cell walls varies with the phase and rate of growth of the
organisms (49-52), raising the possibility that structural
modification of the cell wall, as well as tonicity, may influence
the accessibility of the oxidant to essential chemical targets
on the cell surface. Phenotypic tolerance, that is, the resis-
tance of nongrowing bacteria to a variety of antibiotics, is
a well recognizedphenomenon. In earlier studies, it was pro-
posed that the antimicrobial effect of partially or fully un-
saturated transferrin or lactoferrin (53, 54) was due to the
chelation of iron required for the growth of the organisms.
This mechanism is unlikely to be operative here, since the
addition of Fez + was required.
It is not known whether transferrin- or lactoferrin-
dependent autoxidation of Fe2+ with the generation of toxic
oxidants can occur in vivo. Conditionsin the circulation would
be unfavorable for such a reaction by virtue of the absence
ofappreciable free iron, the relativelyhigh pH, and the pres-
ence ofabundant protein and other scavengers ofoxygen rad-
icals. Transferrin binds to cell surface receptors on macrophages
(55-58), as well as a number of other cell types, and the
transferrin-receptor complex is endocytosed. The fall in pH
in the endorytic vacuole results in the dissociation of iron
from the transferrin, and the apotransferrin bound to its
receptor is returned to the cell surface, where the complex
dissociates, releasing transferrin into the circulation. Reduc-
tion ofthe iron to the ferrous form in the endocytic vacuole
or its membrane has been proposed (59) . Although this pro-
cess is designed primarily to supply iron for cellular needs,
the conditions in theendorytic vacuole may favor radical for-
mation, namely, the presence of Fee+ and apotransferrin in
an acidic environment, with transferrin servingboth as a source
of iron and as a stimulus of Fe2+ autoxidation. Hydroxyl
radicals would have to be formed adjacent to an ingested or-
ganism for an antimicrobial effect to occur. After endocy-
tosis, transferrin is detected in a juxtanuclear compartment
in CHO (60) and K562 (61) cells, and it is not knownwhether
passage into thephagosome occurs in macrophages. It should
be noted in this regard that iron-saturated transferrin pre-
vents the inhibition of Legionella pneumophila multiplication
by activated cultured human monocytes, presumably by pro-
viding the iron required for the growth of the organisms (62).
Lactoferrin is present inhigh concentration in the specific
(secondary) granules of neutrophils and is released into the
phagosome after microbial ingestion (63). Iron-unsaturated
lactoferrin has antimicrobial properties (64-73) that were, in
some studies, favored by a low pH (5.0-6.0) and the use of
organisms in early exponential growth phase (69, 73) . In
general, Fez + was not added in these studies, and in one in-
stance in which it was (69), no effect on the bactericidal effect
of apolactoferrin was observed; however, the experimental
design would allow the detection of an inhibition, but not
a potentiation, of bactericidal activity. Most studies indicate
a fall in pH in the phagosome to a level comparable with
that used here (74), although an early rise may occur (75,
76). It is not known whether adequate amounts of free Fe2+
are available in the phagosome; a potential source of iron is
its release by oxidative attack on the ingested organism (77,
78) or its reductive release from ferritin through the action
of O (79, 80) . Although lactoferrin has been reported to
limit the formation of OH. by the chelation ofiron required
for the Haber-Weiss reaction (1), the studies reported here
raise the possibility that under some conditions potentiation
of OH . formation by lactoferrin may occur. Similarly, a
number of microorganisms contain iron chelators (sidero-
phores) with a high affinity for Fe3+ and a low affinity for
Fez+ (81), which would be expected to facilitate the autoxi-
dation of Fe2+ with-autoinhibition through the formation
of toxic oxidants.
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